Recombinant Mouse PD-L2/B7-DC Fc Chimera Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 1022-PL
Key Product Details
Source
NS0
Accession #
Structure / Form
Disulfide-linked homodimer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Mouse myeloma cell line, NS0-derived mouse PD-L2/B7-DC protein
Mouse PD-L2 (Leu20-Arg219) Accession # Q9WUL5 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.01 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Leu20
Predicted Molecular Mass
49 kDa (monomer)
SDS-PAGE
76 kDa, reducing conditions
Activity
Measured by its ability to inhibit anti-CD3-induced proliferation of stimulated mouse T cells.
The ED50 for this effect is 1-6 µg/mL.
The ED50 for this effect is 1-6 µg/mL.
Reviewed Applications
Read 1 review rated 5 using 1022-PL in the following applications:
Scientific Data Images for Recombinant Mouse PD-L2/B7-DC Fc Chimera Protein, CF
Recombinant Mouse PD-L2/B7-DC Fc Chimera Protein Bioactivity
Recombinant Mouse PD-L2/B7-DC Fc Chimera (Catalog # 1022-PL) inhibits anti-CD3 induced T cell proliferation. The ED50 for this effect is 1-6 μg/mL.Formulation, Preparation and Storage
1022-PL
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 400 μg/mL in sterile PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: PD-L2/B7-DC
PD-L2, along with B7-H1/PD-L1, binds to T cell PD-1 where it promotes IFN-gamma production and CD40 Ligand up-regulation while inhibiting IL-4 production (2, 3, 11, 12). In addition, PD-L2 binds to RGM-B on macrophages and alveolar epithelial cells, supporting respiratory immune tolerance (13). In asthma, PD-L2 suppresses IL-5 and
IL-13 production, promotes IL-12 production by dendritic cells, and supports allergen-induced airway hyper-responsiveness and mucus production (8, 10).
References
- Ceeraz, S. et al. (2013) Trends Immunol. 34:556.
- Latchman, Y. et al. (2001) Nat. Immunol. 2:261.
- Tseng, S.-Y. et al. (2001) J. Exp. Med. 193:839.
- Messal, N. et al. (2011) Mol. Immunol. 48:2214.
- Zuccarino-Catania, G.V. et al. (2014) Nat. Immunol. 15:631.
- Guo, G. et al. (2012) Clin. Rheumatol. 31:271.
- Loke, P. and J.P. Allison (2003) Proc. Natl. Acad. Sci. USA 100:5336.
- Matsumoto, K. et al. (2004) J. Immunol. 172:2530.
- Stanciu, L.A. et al. (2006) J. Infec. Dis. 193:404.
- Lewkowich, I.P. et al. (2013) Mucosal Immun. 6:728.
- Ghiotto, M. et al. (2010) Int. Immunol. 22:651.
- Shin, T. et al. (2003) J. Exp. Med. 198:31.
- Xiao, Y. et al. (2014) J. Exp. Med. 211:943.
Long Name
Programmed Death-1 Ligand-2
Alternate Names
B7-DC, Butyrophilin-like Protein, CD273, PDCD1LG2, PDL2
Gene Symbol
PDCD1LG2
UniProt
Additional PD-L2/B7-DC Products
Product Documents for Recombinant Mouse PD-L2/B7-DC Fc Chimera Protein, CF
Product Specific Notices for Recombinant Mouse PD-L2/B7-DC Fc Chimera Protein, CF
For research use only
Loading...
Loading...
Loading...